Amsterdam Neuroscience

CANTATE-PC: Working towards a blood test to accurately diagnose Alzheimer’s disease The CANTATE-PC study aims to take a first step towards identifying the utility of a blood test that consists of a panel of 5 blood-based biomarkers in primary care.

MIRIADE: Accelerating dementia biomarker development The goal of MIRIADE (Multi‐omics Interdisciplinary Research Integration to Address DEmentia diagnosis) is to train a new generation of young scientists to optimize and accelerate the development of novel biomarkers for dementia.

ABOARD - Stopping Alzheimer’s before it starts ABOARD, short for “A personalized medicine approach for Alzheimer’s disease”, is a public-private project which aims to prepare for a future in which Alzheimer’s disease is stopped before the onset of dementia.

Stopping the progression of MS Why do people with MS continue to deteriorate? How can disease progression be stopped? The researchers at the MS Center Amsterdam want to find answers to these questions.

New, rational therapy decisions for developmental brain disorders The NWA supported NewTDec* consortium takes on the challenge to inform, perform and monitor rational treatments at the patient ‘N-of-1’ level.

Nationwide study on community-acquired bacterial meningitis: from genetics to therapy Genetic studies have provided important clues to which mechanisms play a role in the response to the bacteria and secondary damage to the brain.

Personalized MS Treatment The MS Center Amsterdam want to enable personalized treatments for people with MS. Therefore it is important to know which patient responds best to which medicine.

EEG controlled triage in the ambulance for acute ischemic stroke Endovascular stroke treatment is effective, but performed in selected hospitals. Pre-hospital identification helps paramedics to choose the right hospital.

New treatment strategies for depression by targeting childhood trauma The new research project RESET (REStoring mood after Early life Trauma) aims to alleviate depression in patients with depression and childhood trauma.

ABIDE: Alzheimer’s Biomarkers in Daily Practice To translate diagnostic tests in Alzheimer’s disease (AD) and their related biomarkers’ values to daily practice in local memory clinics.